Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly-Reference-Cited by-同舟云学术

Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly

Published:2015-04-19 Issue:2 Volume:170 Page:179-184
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Stamatoullas Aspasia¹,Brice Pauline²,Bouabdallah Reda³,Mareschal Sylvain⁴,Camus Vincent¹,Rahal Ilhem³,Franchi Patricia²,Lanic Hélène¹,Tilly Hervé¹

Affiliation:

1. Henri Becquerel Centre; Rouen University; Rouen France

2. Saint Louis Hospital; Paris France

3. Paoli Calmette Institute; Marseille France

4. Henri Becquerel Centre; INSERM U918; Rouen France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13419/fullpdf

Reference26 articles.

1. Bleomycin lung toxicity: who are the patients with increased risk?;Azambuja;Pulmonary Pharmacology & Therapeutics,2005

2. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis;Azoulay;Critical Care Medicine,2003

3. Impact of bleomycin and dacarbazine within the ABVD a regimenin the treatment of early-stage favorable Hodgkin Lymphoma: final a results of the GHSG HD13 trial;Behringer;Haematologica,2013

4. Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma;Boll;Blood,2011

5. ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials;Boll;Journal of Clinical Oncology,2013

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients;Leukemia & Lymphoma;2024-09-13

2. Integrating Novel Agents Into the Clinical Management of Classic Hodgkin Lymphoma;JCO Oncology Practice;2024-09-12

3. Treatment approaches for older Hodgkin lymphoma patients;Current Opinion in Oncology;2024-06-20

4. Drug-induced interstitial lung disease: a narrative review of a clinical conundrum;Expert Review of Respiratory Medicine;2024-02

5. Hodgkin lymphoma treatment for older persons in the modern era;Hematology;2023-12-08